Vancomycin-resistant Staphylococcus aureus
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Vancomycin-resistant Staphylococcus aureus | |
|---|---|
| Vancomycin-resistant Staphylococcus aureus | |
| Synonyms | VRSA |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin infection, pneumonia, sepsis |
| Complications | Endocarditis, osteomyelitis, toxic shock syndrome |
| Onset | Varies |
| Duration | Varies |
| Types | N/A |
| Causes | Staphylococcus aureus with antibiotic resistance to vancomycin |
| Risks | Previous antibiotic use, hospitalization, immunocompromised state |
| Diagnosis | Culture, antibiotic susceptibility testing |
| Differential diagnosis | Methicillin-resistant Staphylococcus aureus (MRSA), other bacterial infections |
| Prevention | Infection control, hand hygiene, judicious use of antibiotics |
| Treatment | Alternative antibiotics such as linezolid, daptomycin |
| Medication | N/A |
| Prognosis | Varies, can be severe if untreated |
| Frequency | Rare |
| Deaths | N/A |
Vancomycin-resistant Staphylococcus aureus (VRSA) is a strain of the bacterium Staphylococcus aureus that has developed resistance to the antibiotic vancomycin. This resistance poses significant challenges in the treatment of infections caused by this bacterium.
History[edit]
The first case of VRSA was reported in 2002 in the United States. The emergence of VRSA is a result of the bacterium acquiring the vanA gene from vancomycin-resistant enterococci (VRE), which confers high-level resistance to vancomycin.
Mechanism of resistance[edit]
VRSA acquires resistance through the horizontal transfer of the vanA gene cluster, which alters the target site of vancomycin, reducing its binding affinity. This genetic exchange typically occurs in environments where both VRE and S. aureus are present, such as in hospitals.
Clinical significance[edit]
Infections caused by VRSA are difficult to treat due to limited antibiotic options. VRSA infections can lead to severe outcomes, especially in immunocompromised patients. The resistance to vancomycin necessitates the use of alternative antibiotics, such as linezolid or daptomycin, which may have their own limitations and side effects.
Prevention and control[edit]
Preventing the spread of VRSA involves strict infection control measures in healthcare settings, including hand hygiene, contact precautions, and surveillance cultures. Reducing the use of vancomycin and other antibiotics can also help prevent the development of resistance.
Research and future directions[edit]
Ongoing research aims to develop new antibiotics and alternative therapies to combat VRSA. Efforts are also focused on understanding the genetic mechanisms of resistance and the epidemiology of VRSA to better control its spread.
